Patents by Inventor Ranjan Dohil

Ranjan Dohil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200383909
    Abstract: The disclosure relates to methods and compositions to treat an eosinophilic disease or disorder. More particularly, the disclosure provides methods and compositions for treating eosinophilic esophagitis.
    Type: Application
    Filed: June 6, 2020
    Publication date: December 10, 2020
    Inventors: Seema S. Aceves, Ranjan Dohil, Quan Nhu
  • Publication number: 20200338033
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: November 14, 2019
    Publication date: October 29, 2020
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20200163897
    Abstract: The disclosure relates, in general, to treatment of liver disorders associated with portal and periportal inflammation comprising administering compositions comprising cysteamine and/or cystamine compositions.
    Type: Application
    Filed: June 25, 2018
    Publication date: May 28, 2020
    Inventor: Ranjan Dohil
  • Publication number: 20200101022
    Abstract: The disclosure provides cysteamine salt and cystamine formulations comprising enteric coatings. The disclosure also provides composition for use in treating diseases and disorders that can be treated with cysteamine.
    Type: Application
    Filed: November 16, 2016
    Publication date: April 2, 2020
    Inventor: Ranjan Dohil
  • Patent number: 10537528
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine or cystamine compositions. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: January 21, 2020
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Patrice Rioux
  • Patent number: 10485774
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: November 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20190298665
    Abstract: An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.
    Type: Application
    Filed: December 12, 2018
    Publication date: October 3, 2019
    Inventors: Kathlene POWELL, Ramesh MUTTAVARAPU, Ranjan DOHIL
  • Publication number: 20190201333
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Patent number: 10307386
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 4, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 10272037
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: April 30, 2019
    Assignees: The Regents of the University of California, Meritage Pharma, Inc.
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Publication number: 20190060264
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 28, 2019
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20180338928
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine or cystamine compositions. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: November 16, 2016
    Publication date: November 29, 2018
    Inventors: Ranjan Dohil, Patrice Rioux
  • Patent number: 9925158
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9925157
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9925156
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20180071211
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 15, 2018
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Patent number: 9814689
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: November 14, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319523
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319522
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319524
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider